Conventional Palpation Versus Ultrasound Assisted Spinal Anesthesia in Obstetrics

This was a prospective, randomized controlled trial conducted between Nov 2022 and December 2022 in the gynecological operating room of Mongi Slim hospital.

Ethical approval was provided by our Institutional Hospital Ethics Committee.

Written informed consent was obtained from all the participants.

Study population

1. Inclusion criteria

• Age >18 years old
• Normal singleton pregnancy
• Gestational age ≥ 37 weeks
• BMI ≥ 30 Kg/ m2 (weight measured on the day before delivery)
• Planned cesarean section
• ASA 2-3

1. Non-inclusion criteria

• Patient refusal to participate or unable to provide consent
• Emergency cesarean section
• patient pregnant with twins
• Contraindications to spinal anesthesia:
• Localized sepsis: infection at the puncture site
• allergy to any of the drugs planned fo administration
• raised intracranial pressure
• spine surgery
• aortic stenosis
• Coagulopathy
• hypovolemia

1. Exclusion criteria

• Spinal anesthesia failure
• Poorly Tolerated spinal anesthesia

Methods

All eligible participants scheduled for cesarean delivery were prospectively randomized to 2 groups using computer-generated random numbers:

A standard manual palpation group (standard group, n=45) and a pre-puncture ultrasound-guided neuraxial anesthesia group (ultrasound group, n=45).

The sample size calculation was based on a previous study [1], the first-attempt success rate was 52% in the conventional approach and 87% in the ultrasound group.

With an α error of 5% and a ß error of 20% (80% power), a sample size of 43 patients per group was required. We increased the number to 45 per group to allow dropouts.

The weight, height and BMI of the parturients were measured one day before the delivery.

The degree of obesity was determined according to the classification of body mass index of the world health organization.

In the operating room, patients were monitored with pulse oximetry, non invasive blood pressure and 3-lead electrocardiogram. Intravenous access was established. Randomization was revealed at this time.

Eligible operators for the study were anesthesia fellows and residents in their third and fourth year of training anesthesia. Fellows and residents received didactic teaching in the form of reading material and educational video on spinal sonography before patient recruitment and were instructed on how to perform a standardized spinal ultrasound assessment for neuraxial procedures. The training proceeded with a demonstration on a live model with typical sonoanatomy at all lumbar spaces and were required to perform the following tasks:

1. identification of the sacrum and five lumbar intervertebral spaces in the paramedian sagittal oblique plane.
2. determination of the midline and the interspace at different lumbar interspaces, the optimal needle insertion point and the distance from the skin to the inner aspect of the ligamentum flavum and dura mater unit in the transverse median plane.

A portable ultrasound system (sonosite) equipped with a curved array probe was utilized.

In the standard group, with the parturient in a sitting position, the anaesthesiologist identified the L4-L5 space using the standard palpation method : the imaginary line connecting both upper iliac crests crossing the spine identified the L4-L5 interspace. The duration required to identify the point of puncture is noted.

In the ultrasound group, a preprocedural spinal ultrasound was performed in a non sterile manner with a sitting position. Ultrasound visualization in both paramedian and

transverse planes was performed. The convex transducer was first placed on the sacral region on a longitudinal paramedian presentation, 2-3cm from the midline, angled to the spinal canal which leads to the identification of the sacrum as a continuous hyperechoic line. Then the transducer was moved in a cephalad direction to identify the intervertebral spaces as acoustic windows and spinous processes as acoustic shadows. We draw a transverse line with a disposable skin marker at either the L3-4 or L4-5 interspace. Then we rotate the probe 90 degrees and place transversely to determine the midline, which was marked by a longitudinal line. The intersection of the longitudinal and transverse lines is the point of needle insertion. We tilt the probe slightly up and down to ensure a sufficient echogenic window at the selected intervertebral level. The distance from the skin to the dura mater is noted.

The time required to identify the insertion site is noted.

In both groups, we record the procedure time which is time from the handle of the spinal needle to observe free flow of cerebrospinal fluid.

After a full aseptic painting, spinal anesthesia was administered using a 25-gauge, 90-mm pencil-point needle inserted through a 20-gauge introducer needle with hyperbaric bupivacaine, 2,5 μg sufentanil and preservative-free morphine 100μg.

The dose of bupivacaine will be selected based on the height of the parturient as shown in the table below (table1).

The patient was positioned supine with left uterine displacement then surgery was allowed to proceed once bilateral sensory block to cold spray to T4 was achieved.

Outcome measures

primary outcome:

-First pass success rate without needle redirection or reinsertion.

Secondary outcomes:

1. Number of puncture attempts : new skin puncture at the same or different interspace
2. Number of intervertebral interspaces attempted
3. Requirement of needle redirection : any withdrawal and re-advancement of the spinal needle and/or introducer within an intervertebral space
4. Procedure Time ( total time required for the identification + time from first placement of the introducer until free flow of cerebrospinal fluid.
5. Patient satisfaction score.
6. Possible complications:

• Traumatic procedure
• Postdural puncture headache
• Development of back pain post spinal anesthesia
• paresthesia

Ethical Considerations:

All patients were included after obtaining their informed consent (Appendix).

Participation was voluntary and anonymous.

We explained to the participants:

• The usefulness of this study
• Absence of significant adverse effects at this dose (low dose).
• The possibility of accepting or refusing participation.
• The possibility of leaving the study at any time